Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Timber Pharmaceuticals, Inc. | Financial_Report.xls |
| EX-31.1 - EX-31.1 - Timber Pharmaceuticals, Inc. | a2223386zex-31_1.htm |
| EX-4.3 - EX-4.3 - Timber Pharmaceuticals, Inc. | a2223386zex-4_3.htm |
| EX-21.1 - EX-21.1 - Timber Pharmaceuticals, Inc. | a2223386zex-21_1.htm |
| EX-32.1 - EX-32.1 - Timber Pharmaceuticals, Inc. | a2223386zex-32_1.htm |
| EX-10.4 - EX-10.4 - Timber Pharmaceuticals, Inc. | a2223386zex-10_4.htm |
| EX-10.15 - EX-10.15 - Timber Pharmaceuticals, Inc. | a2223386zex-10_15.htm |
| 10-K - 10-K - Timber Pharmaceuticals, Inc. | a2223386z10-k.htm |
| EX-4.2 - EX-4.2 - Timber Pharmaceuticals, Inc. | a2223386zex-4_2.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-201708) of BioPharmX Corporation of our report dated March 30, 2015 relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K.
/s/ Burr Pilger Mayer, Inc.
San
Jose, California
March 30, 2015
Consent of Independent Registered Public Accounting Firm